IL-1 Receptor Accessory Protein is Essential for IL-33-induced Activation of T Lymphocytes and Mast Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Nov 16

PMID 18003919

Citations 135

Authors

Shafaqat Ali

Michael Huber

Christian Kollewe

Stephan C Bischoff

Werner Falk

Michael U Martin

Affiliations

Soon will be listed here.

Abstract

Lack of the IL-1 receptor accessory protein (IL-1RAcP) abrogates responses to IL-33 and IL-1 in the mouse thymoma clone EL-4 D6/76 cells. Reconstitution with full-length IL-1RAcP is sufficient to restore responsiveness to IL-33 and IL-1. IL-33 activates IL-1 receptor-associated kinase-1, cJun-N-terminal kinase, and the NF-kappaB pathway in an IL-1RAcP-dependent manner and results in IL-2 release. IL-33 is able to induce the release of proinflammatory cytokines in bone marrow-derived (BMD) mast cells, indicating that IL-33 may have a proinflammatory potential like its relatives IL-1 and IL-18, in addition to its Th2-skewing properties in the adaptive response described previously. Blocking of murine IL-1RAcP with the neutralizing antibody 4C5 inhibits response of mouse thymoma cells and BMD mast cells to IL-33. The interaction of either membrane-bound or soluble forms of IL-1RAcP and IL-33Ralpha-chain depends on the presence of IL-33, as demonstrated by coimmunoprecipitation assays. These data demonstrate that IL-1RAcP is indispensable for IL-33 signaling. Furthermore, they suggest that IL-1RAcP is used by more than one alpha-chain of the IL-1 receptor family and thus may resemble a common beta-chain of that family.

Citing Articles

Interleukin-33: A Double-Edged Sword in Sepsis.

Liu S, Yue Y, Wu Q, Zhang L Transl Perioper Pain Med. 2025; 11(2):612-619.

PMID: 39991638 PMC: 11845250. DOI: 10.31480/2330-4871/188.

Novel insights: crosstalk with non-puerperal mastitis and immunity.

Zhou Y, Gong J, Deng X, Shen L, Liu L Front Immunol. 2024; 15:1431681.

PMID: 39148739 PMC: 11324573. DOI: 10.3389/fimmu.2024.1431681.

A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathy.

Bisen S, Verma S, Sekhar Mukhopadhyay C, Singh N Exp Mol Med. 2024; 56(8):1703-1716.

PMID: 39085349 PMC: 11372157. DOI: 10.1038/s12276-024-01279-y.

Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives.

Zhou Y, Xu Z, Liu Z J Transl Med. 2023; 21(1):902.

PMID: 38082335 PMC: 10714644. DOI: 10.1186/s12967-023-04782-4.

Promoting New Approach Methodologies (NAMs) for research on skin color changes in response to environmental stress factors: tobacco and air pollution.

Bouchard K, Costin G Front Toxicol. 2023; 5:1256399.

PMID: 37886123 PMC: 10598764. DOI: 10.3389/ftox.2023.1256399.

References

Knop J, Wesche H, Lang D, Martin M . Effects of overexpression of IL-1 receptor-associated kinase on NFkappaB activation, IL-2 production and stress-activated protein kinases in the murine T cell line EL4. Eur J Immunol. 1998; 28(10):3100-9. DOI: 10.1002/(SICI)1521-4141(199810)28:10<3100::AID-IMMU3100>3.0.CO;2-7. View

Sims J . IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol. 2002; 14(1):117-22. DOI: 10.1016/s0952-7915(01)00306-5. View

Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W . Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem. 1997; 272(44):27730-6. DOI: 10.1074/jbc.272.44.27730. View

Smith D, Hanna R, Friend D, Moore H, Chen H, Farese A . The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity. 2003; 18(1):87-96. DOI: 10.1016/s1074-7613(02)00514-9. View

Radons J, Gabler S, Wesche H, Korherr C, Hofmeister R, Falk W . Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling. J Biol Chem. 2002; 277(19):16456-63. DOI: 10.1074/jbc.M201000200. View

Schreuder H, Tardif C, Soffientini A, Sarubbi E, AKESON A, Bowlin T . A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 1997; 386(6621):194-200. DOI: 10.1038/386194a0. View

Brint E, Fitzgerald K, Smith P, Coyle A, Gutierrez-Ramos J, Fallon P . Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. J Biol Chem. 2002; 277(51):49205-11. DOI: 10.1074/jbc.M209685200. View

Boraschi D, Tagliabue A . The interleukin-1 receptor family. Vitam Horm. 2006; 74:229-54. DOI: 10.1016/S0083-6729(06)74009-2. View

Born T, Smith D, Garka K, Renshaw B, Bertles J, Sims J . Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem. 2000; 275(39):29946-54. DOI: 10.1074/jbc.M004077200. View

10.

Subramaniam S, Stansberg C, Cunningham C . The interleukin 1 receptor family. Dev Comp Immunol. 2004; 28(5):415-28. DOI: 10.1016/j.dci.2003.09.016. View

11.

Chackerian A, Oldham E, Murphy E, Schmitz J, Pflanz S, Kastelein R . IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007; 179(4):2551-5. DOI: 10.4049/jimmunol.179.4.2551. View

12.

Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D . The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol. 1998; 161(12):6871-7. View

13.

Dinarello C . An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity. 2005; 23(5):461-2. DOI: 10.1016/j.immuni.2005.10.004. View

14.

Hayakawa H, Hayakawa M, Kume A, Tominaga S . Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007; 282(36):26369-80. DOI: 10.1074/jbc.M704916200. View

15.

Allakhverdi Z, Smith D, Comeau M, Delespesse G . Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol. 2007; 179(4):2051-4. DOI: 10.4049/jimmunol.179.4.2051. View

16.

Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y . IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007; 87(10):971-8. DOI: 10.1038/labinvest.3700663. View

17.

Cullinan E, Kwee L, Nunes P, Shuster D, Ju G, McIntyre K . IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol. 1998; 161(10):5614-20. View

18.

Torigoe K, USHIO S, Okura T, Kobayashi S, Taniai M, Kunikata T . Purification and characterization of the human interleukin-18 receptor. J Biol Chem. 1997; 272(41):25737-42. DOI: 10.1074/jbc.272.41.25737. View

19.

Born T, Thomassen E, Bird T, Sims J . Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem. 1998; 273(45):29445-50. DOI: 10.1074/jbc.273.45.29445. View

20.

Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M . SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol. 2004; 174(1):507-16. DOI: 10.4049/jimmunol.174.1.507. View